within Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L04A_Immunosuppressants.L04AF01_Tofacitinib;

model Tofacitinib
  extends Pharmacolibrary.Drugs.ATC.L.L04AF01;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>L04AF01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Tofacitinib is an oral Janus kinase (JAK) inhibitor used for the treatment of autoimmune diseases such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. It is approved for use in adults and functions by modulating the immune response.</p><h4>Pharmacokinetics</h4><p>Healthy adult subjects, single-dose, oral administration.</p><h4>References</h4><ol><li><p>Sandborn, WJ, et al., &amp; Panés, J (2017). Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis. <i>The New England journal of medicine</i> 376(18) 1723–1736. DOI:<a href=\"https://doi.org/10.1056/NEJMoa1606910\">10.1056/NEJMoa1606910</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/28467869/\">https://pubmed.ncbi.nlm.nih.gov/28467869</a></p></li><li><p>Eichinger, JM, et al., &amp; Feldman, SR (2024). Clinical pharmacokinetics and pharmacodynamics of oral systemic nonbiologic therapies for psoriasis patients. <i>Expert opinion on drug metabolism &amp; toxicology</i> 20(4) 249–262. DOI:<a href=\"https://doi.org/10.1080/17425255.2024.2335310\">10.1080/17425255.2024.2335310</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/38529623/\">https://pubmed.ncbi.nlm.nih.gov/38529623</a></p></li><li><p>Azevedo, A, &amp; Torres, T (2018). Tofacitinib: A New Oral Therapy for Psoriasis. <i>Clinical drug investigation</i> 38(2) 101–112. DOI:<a href=\"https://doi.org/10.1007/s40261-017-0596-y\">10.1007/s40261-017-0596-y</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/29094282/\">https://pubmed.ncbi.nlm.nih.gov/29094282</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Tofacitinib;
